| 1 |
34826419 | Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells. | 2022 Jan |
1 |
| 2 |
33465165 | Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2. | 2021 Jan |
2 |
| 3 |
32664879 | New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. | 2020 Jul 15 |
1 |
| 4 |
32793908 | Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells. | 2020 Sep 2 |
1 |
| 5 |
33390974 | Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review. | 2020 |
1 |